VTRO (Vitro Biopharma) Accounts Payable: $0.61 Mil (As of Oct. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vitro Biopharma Accounts Payable?

Vitro Biopharma VTRO Accounts Payable is $0.61 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's Accounts Payable for the quarter that ended in Oct. 2022 was $0.61 Mil.

Vitro Biopharma's quarterly Accounts Payable increased from Oct. 2017 ($0.05 Mil) to Oct. 2021 ($0.06 Mil) and increased from Oct. 2021 ($0.06 Mil) to Oct. 2022 ($0.61 Mil).

Vitro Biopharma's annual Accounts Payable increased from Oct. 2017 ($0.05 Mil) to Oct. 2021 ($0.06 Mil) and increased from Oct. 2021 ($0.06 Mil) to Oct. 2022 ($0.61 Mil).

Vitro Biopharma Accounts Payable Related Terms

Vitro Biopharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Accounts Payable Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.06 0.05 0.06 0.61

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.06 0.05 0.06 0.61

Vitro Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.61 Mil mean?
Vitro Biopharma (VTRO) has a Accounts Payable of $0.61 Mil as of Oct. 2022. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's Accounts Payable too high?
Vitro Biopharma's current Accounts Payable is $0.61 Mil.
How does Vitro Biopharma's Accounts Payable compare to ?
Vitro Biopharma's Accounts Payable of $0.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current Accounts Payable is $0.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Accounts Payable of $0.61 Mil. The current Accounts Payable is $0.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Accounts Payable is $0.61 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.